Who owns SAB BIOTHERAPEUTICS INC?
- Ticker: SABSW
- CUSIP Number: 78397t111
Tip: Access positions for across all investors
Analyze quarterly positions in Sab Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sab Biotherapeutics stock
Who bought or sold SAB BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| LMR Partners | 540k | $21k | 0% | Mar 2024 |
|
| Shaolin Capital Management | 293k | $11k | -37% | Mar 2024 |
|
| Morgan Stanley | 149k | $4.5k | 0% | Mar 2024 |
|
| Yakira Capital Management | 109k | $3.9k | 0% | Mar 2024 |
|
| Millennium Management | 63k | $2.4k | 0% | Mar 2024 |
|
| Walleye Trading Advisors | 23k | $907.062000 | 0% | Mar 2024 |
|
| Wolverine Asset Management | 23k | $888.537000 | 0% | Mar 2024 |
|
| Walleye Trading | 16k | $604.695000 | 0% | Mar 2024 |
|
| Susquehanna International | 12k | $482.274000 | 100% | Mar 2024 |
|
| Goss Wealth Management | 1.1k | $42.022400 | 0% | Mar 2024 |
|
| Bank of America Corporation | 100.00 | $3.000000 | 100% | Mar 2024 |
|
| Clear Street | 100.00 | $0 | 100% | Mar 2024 |
|
| Tower Research Capital | 48.00 | $2.001600 | 0% | Mar 2024 |
|
Who sold out of Sab Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Dec 2023 | 29k | $872.400000 |